Keiko Kawaguchi

2.3k total citations · 2 hit papers
28 papers, 1.7k citations indexed

About

Keiko Kawaguchi is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Keiko Kawaguchi has authored 28 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 4 papers in Immunology and 3 papers in Infectious Diseases. Recurrent topics in Keiko Kawaguchi's work include Influenza Virus Research Studies (9 papers), Respiratory viral infections research (7 papers) and Viral Infections and Immunology Research (3 papers). Keiko Kawaguchi is often cited by papers focused on Influenza Virus Research Studies (9 papers), Respiratory viral infections research (7 papers) and Viral Infections and Immunology Research (3 papers). Keiko Kawaguchi collaborates with scholars based in Japan, United States and Netherlands. Keiko Kawaguchi's co-authors include Takeki Uehara, Takao Shishido, Kenji J. Tsuchiya, Frederick G. Hayden, Nelson Lee, Simon Portsmouth, Nobuo Hirotsu, Nobuhiro Haruki, Adriana González and Thao P. Dang and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Keiko Kawaguchi

28 papers receiving 1.6k citations

Hit Papers

Baloxavir Marboxil for Uncomplicated Influenza in Adults ... 2018 2026 2020 2023 2018 2018 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keiko Kawaguchi Japan 12 1.0k 542 363 227 174 28 1.7k
Xuefeng Zhang China 13 537 0.5× 329 0.6× 191 0.5× 189 0.8× 221 1.3× 51 1.2k
Takasuke Fukuhara Japan 25 896 0.9× 636 1.2× 399 1.1× 348 1.5× 413 2.4× 123 2.6k
Mayte Coiras Spain 24 676 0.7× 437 0.8× 739 2.0× 422 1.9× 78 0.4× 69 1.9k
Shinya Maekawa Japan 28 950 0.9× 666 1.2× 257 0.7× 338 1.5× 362 2.1× 116 2.7k
Anna Ruggieri Italy 23 771 0.7× 690 1.3× 412 1.1× 222 1.0× 98 0.6× 50 2.0k
John D. Burczak United States 17 1.0k 1.0× 522 1.0× 101 0.3× 198 0.9× 141 0.8× 27 2.3k
David M. Owen United States 13 1.1k 1.0× 646 1.2× 314 0.9× 1.3k 5.8× 178 1.0× 23 2.7k
Chen Pan China 11 1.6k 1.5× 353 0.7× 314 0.9× 202 0.9× 188 1.1× 32 2.0k
Brian Doehle United States 29 2.0k 1.9× 841 1.6× 1.0k 2.9× 675 3.0× 89 0.5× 52 3.7k

Countries citing papers authored by Keiko Kawaguchi

Since Specialization
Citations

This map shows the geographic impact of Keiko Kawaguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiko Kawaguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiko Kawaguchi more than expected).

Fields of papers citing papers by Keiko Kawaguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiko Kawaguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiko Kawaguchi. The network helps show where Keiko Kawaguchi may publish in the future.

Co-authorship network of co-authors of Keiko Kawaguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Keiko Kawaguchi. A scholar is included among the top collaborators of Keiko Kawaguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiko Kawaguchi. Keiko Kawaguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ishiguro, Nobuhisa, Ichiro Morioka, T. Nakano, et al.. (2025). Clinical and Virologic Outcomes of Baloxavir Compared with Oseltamivir in Pediatric Patients with Influenza in Japan. Infectious Diseases and Therapy. 14(4). 833–846. 1 indexed citations
2.
Hamasuna, Ryoichi, et al.. (2020). Sensitivity of a transcription-mediated amplification method (Aptima Mycoplasma genitalium assay) to detect M. genitalium in vitro. Journal of Infection and Chemotherapy. 27(4). 573–577. 2 indexed citations
3.
Ikematsu, Hideyuki, Frederick G. Hayden, Keiko Kawaguchi, et al.. (2020). Baloxavir Marboxil for Prophylaxis against Influenza in Household Contacts. New England Journal of Medicine. 383(4). 309–320. 99 indexed citations
4.
Watanabe, Akira, Tadashi Ishida, Nobuo Hirotsu, et al.. (2019). Baloxavir marboxil in Japanese patients with seasonal influenza: Dose response and virus type/subtype outcomes from a randomized phase 2 study. Antiviral Research. 163. 75–81. 22 indexed citations
5.
Omoto, Shinya, Valentina Speranzini, Takashi Hashimoto, et al.. (2018). Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil. Scientific Reports. 8(1). 9633–9633. 312 indexed citations breakdown →
6.
Hayden, Frederick G., Norio Sugaya, Nobuo Hirotsu, et al.. (2018). Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents. New England Journal of Medicine. 379(10). 913–923. 595 indexed citations breakdown →
9.
Obara, Wataru, Masatoshi Eto, Hiromitsu Mimata, et al.. (2016). A phase I/II study of cancer peptide vaccine S-288310 in patients with advanced urothelial carcinoma of the bladder. Annals of Oncology. 28(4). 798–803. 44 indexed citations
10.
Deva, Sanjeev, Richard D. Baird, Nicola Cresti, et al.. (2015). Phase I expansion of S-222611, a reversible inhibitor of EGFR and HER2, in advanced solid tumors, including patients with brain metastases.. Journal of Clinical Oncology. 33(15_suppl). 2511–2511. 5 indexed citations
11.
Kawaguchi, Keiko, Kunio Kawanishi, Masayo Sato, et al.. (2015). Atypical hemolytic uremic syndrome diagnosed four years after ABO‐incompatible kidney transplantation. Nephrology. 20(S2). 61–65. 2 indexed citations
12.
Yamazaki, Atsuko & Keiko Kawaguchi. (2012). Enhancing the global awareness of graduate students through an advanced engineering English course for multi-national students. 50–55. 1 indexed citations
13.
Konishi, Jun, Keiko Kawaguchi, Nobuhiro Haruki, et al.. (2007). γ-Secretase Inhibitor Prevents Notch3 Activation and Reduces Proliferation in Human Lung Cancers. Cancer Research. 67(17). 8051–8057. 220 indexed citations
14.
Kawaguchi, Keiko, et al.. (2005). A Study of the Relationship between TOEIC Scores and Functional Job Performance: Self-assessment of Foreign Language Proficiency. 1–40. 6 indexed citations
15.
Kawaguchi, Keiko, et al.. (2005). Efficacy of Kampo Medical Treatment Focused on Kami-syoyo-san against Premenstrual Syndrome (PMS). Kampo Medicine. 56(1). 109–114. 3 indexed citations
16.
Tachihara, Katsunori & Keiko Kawaguchi. (2003). Morphological development of eggs, larvae and juveniles of laboratory-reared Ryukyu-ayu Plecoglossus altivelis ryukyuensis. Fisheries Science. 69(2). 323–330. 17 indexed citations
17.
Kawaguchi, Keiko, et al.. (1988). Comparative study of varying techniques for cervical cytology. Cytobrush versus cotton swab.. The Journal of the Japanese Society of Clinical Cytology. 27(1). 7–13. 1 indexed citations
18.
Kawaguchi, Keiko, et al.. (1987). The value of the cytobrush for obtaining cells from the uterine cervix. Diagnostic Cytopathology. 3(3). 262–267. 25 indexed citations
19.
Sasaki, Masanori, et al.. (1986). [Effect of isepamicin (HAPA-B) on reproduction. I. Fertility study in rats (intramuscular administration)].. PubMed. 39(12). 3283–310. 1 indexed citations
20.
Fujita, Hiroshi, et al.. (1983). [Pharmacokinetics of 5'-deoxy-5-fluorouridine (5'-DFUR)].. PubMed. 18(4). 916–26. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026